Free Newsletter
What's next for Genentech employees?
Imagine you're a Genentech worker in San Diego. Since Roche and Genentech first signed their partnership deal in the 1990s, you've enjoyed a relatively hands-off approach that's allowed independent research to thrive. In fact, Roche's affiliation with Genentech is regarded as the gold standard of what a Big Pharma's relationship with a small biotech should be. Article
More stories about Genentech
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: